ACTIQ Side Effects

7021081-5 | Colon Cancer, Hypotension, Loss Of Consciousness
on Sep 24, 2010 Female patient from FRANCE , 60 years of age, was diagnosed with cancer pain and was treated with Actiq (View Usage). Patient experienced the following unwanted or unexpected effects: colon cancer, hypotension, loss of consciousness. Actiq dosage: .

7021070-0 | Lung Neoplasm Malignant
Patient was taking Actiq (View Usage). Patient had the following side effects: lung neoplasm malignant on Sep 24, 2010 from FRANCE Additional patient health information: Male patient , 60 years of age, was diagnosed with cancer pain and. Actiq dosage: .

6934136-8 | Dental Caries
Adverse event was reported on Aug 12, 2010 by a Female patient taking Actiq (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?), contraception, pain (What is pain?) and. Location: , weighting 119.0 lb, After Actiq was administered, patient had the following side effects: dental caries. During the same period patient was treated with OVCON 35 (Daily: 1 Tab/cap; Unit: 1 Tab/cap; Form: 1 Tab/cap;) (View Ovcon-35 Review and Ovcon-35 Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ).

6909386-7 | Accidental Overdose
on Aug 04, 2010 Male patient from UNITED STATES , 20 years of age, was treated with Actiq (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose. Actiq dosage: .


6899624-1 | Dental Caries
on Jul 28, 2010 Female patient from UNITED STATES , weighting 119.0 lb, was diagnosed with crohn's disease (What is crohn's disease?), contraception, pain (What is pain?) and was treated with Actiq (View Usage). Patient had the following side effects: dental caries. Actiq dosage: . During the same period patient was treated with OVCON 35 (Daily: 1 Tab/cap; Unit: 1 Tab/cap; Form: 1 Tab/cap;) (View Ovcon-35 Review and Ovcon-35 Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ).

6844906-2 | Tooth Erosion, Weight Increased
Patient was taking Actiq (View Usage). After Actiq was administered, patient had the following side effects: tooth erosion, weight increased on Jul 09, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 174.2 lb, was diagnosed with pain (What is pain?), muscle spasms and. Actiq dosage: . During the same period patient was treated with FENTANYL 75 (View Fentanyl-75 Review and Fentanyl-75 Label ), EFFEXOR (View Effexor Review and Effexor Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6840369-1 | Fungal Infection, Gingival Bleeding, Gingival Recession, Pleurisy, Pneumonia, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Tooth Loss
Adverse event was reported on Jul 07, 2010 by a Male patient taking Actiq (View Usage) (Dosage: ) was diagnosed with pain (What is pain?), insomnia, anxiety (What is anxiety?), headache (What is headache?) and. Location: UNITED STATES , weighting 229.3 lb, Patient experienced the following unwanted or unexpected effects: fungal infection (What is fungal infection?), gingival bleeding, gingival recession, pleurisy, pneumonia (What is pneumonia?), rheumatoid arthritis (What is rheumatoid arthritis?), systemic lupus erythematosus, tooth loss. During the same period patient was treated with PROSOM (View Prosom Review and Prosom Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), BUTALBITAL/ACETAMINOPHEN (View Butalbital/acetaminophen Review and Butalbital/acetaminophen Label ). Patient was hospitalized and became disabled.

6827295-9 | Asthenia, Bradycardia, Extrasystoles, Somnolence
on Jul 04, 2010 Female patient from SPAIN , 76 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Actiq (View Usage). Patient had the following side effects: asthenia, bradycardia, extrasystoles, somnolence. Actiq dosage: . During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), MINITRAN (View Minitran Review and Minitran Label ). Patient was hospitalized.

6771159-6 | Pain, Pulmonary Congestion, Pulmonary Oedema
on Jun 08, 2010 Female patient from UNITED STATES , weighting 209.4 lb, was diagnosed with abdominal pain (What is abdominal pain?), neuropathy peripheral, depression (What is depression?), restless legs syndrome, nausea (What is nausea?), urinary tract infection (What is urinary tract infection?) and was treated with Actiq (View Usage). After Actiq was administered, patient had the following side effects: pain (What is pain?), pulmonary congestion, pulmonary oedema. Actiq dosage: . During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), REQUIP (View Requip Review and Requip Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ).

6763035-X | Accidental Overdose, Arteriosclerosis, Brain Injury, Cardio-respiratory Arrest, Dependence, Depressed Level Of Consciousness
Patient was taking Actiq (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, arteriosclerosis, brain injury, cardio-respiratory arrest, dependence, depressed level of consciousness on Apr 30, 2010 from UNITED STATES Additional patient health information: Male patient , 46 years of age, . Actiq dosage: . During the same period patient was treated with LORTAB (View Lortab Review and Lortab Label ), PERCOCET (View Percocet Review and Percocet Label ), METHADOSE (View Methadose Review and Methadose Label ), SOMA (View Soma Review and Soma Label ), VALIUM (View Valium Review and Valium Label ), MEPROBAMATE (View Meprobamate Review and Meprobamate Label ).

6732608-2 | Dental Caries
Adverse event was reported on May 10, 2010 by a Male patient taking Actiq (View Usage) (Dosage: ) was diagnosed with back pain (What is back pain?), muscle spasms, stress (What is stress?), thyroid disorder and. Location: , weighting 160.9 lb, Patient had the following side effects: dental caries. During the same period patient was treated with FENTORA (View Fentora Review and Fentora Label ), OPANA (Two Tablets Every 8 Hours) (View Opana Review and Opana Label ), OPANA ER (4 Tablets Daily) (View Opana Er Review and Opana Er Label ), VALIUM (View Valium Review and Valium Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6711106-6 | Artificial Crown Procedure, Convulsion, Dental Caries, Face And Mouth X-ray, Formication, Insomnia
on Apr 26, 2010 Female patient from UNITED STATES , weighting 125.7 lb, was diagnosed with fibromyalgia, migraine (What is migraine?), trigeminal neuralgia (What is trigeminal neuralgia?), osteoarthritis (What is osteoarthritis?) and was treated with Actiq (View Usage). After Actiq was administered, patient had the following side effects: artificial crown procedure, convulsion, dental caries, face and mouth x-ray, formication, insomnia. Actiq dosage: . During the same period patient was treated with OXCARBAZEPINE (View Oxcarbazepine Review and Oxcarbazepine Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

6667475-9 |
on Mar 31, 2010 Female patient from UNITED KINGDOM , 55 years of age, was diagnosed with nausea (What is nausea?) and was treated with Actiq (View Usage). . Actiq dosage: . During the same period patient was treated with EMEND (View Emend Review and Emend Label ).

6613681-9 | Gastrointestinal Disorder, Inflammation, Pancreatic Neoplasm
Patient was taking Actiq (View Usage). Patient had the following side effects: gastrointestinal disorder, inflammation, pancreatic neoplasm on Feb 23, 2010 from UNITED STATES Additional patient health information: Female patient , 49 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Actiq dosage: 4800 Mcg (1200 Mcg, 4 In 1 D), Bu. Patient was hospitalized.

6599885-2 | Tooth Discolouration, Tooth Loss
Adverse event was reported on Feb 08, 2010 by a Female patient taking Actiq (View Usage) (Dosage: 6400 Mcg (1600 Mcg, 4 In 1 D), Buccal) was diagnosed with back pain (What is back pain?) and. Location: UNITED STATES , 64 years of age, weighting 155.0 lb, After Actiq was administered, patient had the following side effects: tooth discolouration, tooth loss. During the same period patient was treated with METHADONE (METHADONE) (10 MILLIGRAM) (View Methadone (methadone) (10 Milligram) Review and Methadone (methadone) (10 Milligram) Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), VALIUM (View Valium Review and Valium Label ), SOMA (View Soma Review and Soma Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), MORPHINE SULFATE (HYDROMORPHONE HYDROCHLORIDE) (View Morphine Sulfate (hydromorphone Hydrochloride) Review and Morphine Sulfate (hydromorphone Hydrochloride) Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6596798-7 | Cardiac Arrest, Device Failure, Pulse Absent, Therapeutic Agent Toxicity
on Jan 22, 2010 Female patient from UNITED STATES , 28 years of age, weighting 72.00 lb, was diagnosed with back pain (What is back pain?) and was treated with Actiq (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), device failure, pulse absent, therapeutic agent toxicity. Actiq dosage: 2400 Mcg (600 Mcg, 4 In 1 D), Bu. During the same period patient was treated with DURAGESIC 100 (Transdermal) (View Duragesic-100 Review and Duragesic-100 Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), IMITREXT (SUMATRIPTAN) (View Imitrext (sumatriptan) Review and Imitrext (sumatriptan) Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), OXYCODONE HCL (OXYCODONE HYDROCHLORIDE) (View Oxycodone Hcl (oxycodone Hydrochloride) Review and Oxycodone Hcl (oxycodone Hydrochloride) Label ).

6596569-1 | Kidney Infection
on Feb 22, 2010 Female patient from UNITED STATES , weighting 129.2 lb, was treated with Actiq (View Usage). Patient had the following side effects: kidney infection. Actiq dosage: 200 Microgram Once Buccal. Patient was hospitalized.

6595156-9 | Hepatitis
Patient was taking Actiq (View Usage). After Actiq was administered, patient had the following side effects: hepatitis (What is hepatitis?) on Feb 03, 2010 from UNITED STATES Additional patient health information: Male patient , 42 years of age, weighting 200.0 lb, was diagnosed with neck pain and. Actiq dosage: 4800 Mcg (1200 Mcg, 4 In 1 D), Bu. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), PERCOCET (View Percocet Review and Percocet Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), DURAGESIC (PARACETAMOL, ORPHENADRINE CITRATE) (View Duragesic (paracetamol, Orphenadrine Citrate) Review and Duragesic (paracetamol, Orphenadrine Citrate) Label ). Patient was hospitalized.

6593081-0 | Acidosis, Contraindication To Medical Treatment, Encephalopathy, Hypoglycaemia, Hypotension, Oliguria, Pco2 Decreased, Po2 Increased
Adverse event was reported on Feb 01, 2010 by a Female patient taking Actiq (View Usage) (Dosage: (100 Mcg)) was diagnosed with procedural pain and. Location: UNITED KINGDOM , 29 years of age, Patient experienced the following unwanted or unexpected effects: acidosis, contraindication to medical treatment, encephalopathy, hypoglycaemia, hypotension, oliguria, pco2 decreased, po2 increased. During the same period patient was treated with ISOFLURANE (View Isoflurane Review and Isoflurane Label ), EPHEDRINE SUL CAP (View Ephedrine Sul Cap Review and Ephedrine Sul Cap Label ), MORPHINE (View Morphine Review and Morphine Label ), NITROUS OXIDE W/ OXYGEN (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), SODIUM CITRATE (View Sodium Citrate Review and Sodium Citrate Label ), SUXAMETHONIUM (SUXAMETHONIUM) (View Suxamethonium (suxamethonium) Review and Suxamethonium (suxamethonium) Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ). Patient was hospitalized.

6593080-9 | Biliary Dilatation, Blood Magnesium Decreased, Hypocalcaemia, Hypokalaemia, Intestinal Obstruction, Metabolic Alkalosis
on Feb 02, 2010 Female patient from SPAIN , 65 years of age, was diagnosed with complex regional pain syndrome (What is complex regional pain syndrome?) and was treated with Actiq (View Usage). Patient had the following side effects: biliary dilatation, blood magnesium decreased, hypocalcaemia, hypokalaemia, intestinal obstruction, metabolic alkalosis. Actiq dosage: 900 Mcg (400 Mcg), Bu. During the same period patient was treated with MST 100 CONTINUA(MORPHINE SULFATE) (200 Mcg (100 Mg), Oral) (View Mst 100 Continua(morphine Sulfate) Review and Mst 100 Continua(morphine Sulfate) Label ). Patient was hospitalized.

6593078-0 | Infusion Site Pain, Neutropenia, Pulmonary Embolism, Pyrexia, Vein Pain, Vomiting
on Feb 02, 2010 Female patient from UNITED KINGDOM , 68 years of age, was diagnosed with transitional cell carcinoma and was treated with Actiq (View Usage). After Actiq was administered, patient had the following side effects: infusion site pain, neutropenia, pulmonary embolism (What is pulmonary embolism?), pyrexia, vein pain, vomiting. Actiq dosage: . During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), IBUPROFEN TABLETS (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ). Patient was hospitalized.

6580890-7 | Cardiac Arrest, Heart Valve Incompetence, Peripheral Coldness
Patient was taking Actiq (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), heart valve incompetence, peripheral coldness on Jan 22, 2010 from UNITED STATES Additional patient health information: Female patient , 28 years of age, weighting 72.00 lb, was diagnosed with back pain (What is back pain?) and. Actiq dosage: 2400 Mcg (600 Mcg, 4 In 1 D), Bu. During the same period patient was treated with DURAGESIC 100 (Transdermal) (View Duragesic-100 Review and Duragesic-100 Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), IMITREX (View Imitrex Review and Imitrex Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), OXYCODONE HCL (OXYCODONE HYDROCHLORIDE) (View Oxycodone Hcl (oxycodone Hydrochloride) Review and Oxycodone Hcl (oxycodone Hydrochloride) Label ).

6575254-6 | Inflammation, Pancreatic Neoplasm, Parenteral Nutrition, Sphincter Of Oddi Dysfunction
Adverse event was reported on Dec 02, 2009 by a Female patient taking Actiq (View Usage) (Dosage: Bu) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 49 years of age, Patient had the following side effects: inflammation, pancreatic neoplasm, parenteral nutrition, sphincter of oddi dysfunction. Patient was hospitalized.

6575253-4 | Dental Caries, Obesity Surgery
on Jan 22, 2010 Male patient from UNITED STATES , 48 years of age, weighting 175.0 lb, was diagnosed with pain (What is pain?) and was treated with Actiq (View Usage). After Actiq was administered, patient had the following side effects: dental caries, obesity surgery. Actiq dosage: See Image. During the same period patient was treated with FENTANYL PATCH (PARACETAMOL, ORPHENADRINE CITRATE) (TRANSDERMAL PATCH) (View Fentanyl Patch (paracetamol, Orphenadrine Citrate) (transdermal Patch) Review and Fentanyl Patch (paracetamol, Orphenadrine Citrate) (transdermal Patch) Label ), EFFEXOR (View Effexor Review and Effexor Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6568411-6 | Acidosis, Encephalopathy, Hypoglycaemia, Hypotension, Oliguria
on Jan 19, 2010 Female patient from UNITED KINGDOM , 29 years of age, was diagnosed with procedural pain and was treated with Actiq (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, encephalopathy, hypoglycaemia, hypotension, oliguria. Actiq dosage: (100 Mcg). During the same period patient was treated with ISOFLURANE (View Isoflurane Review and Isoflurane Label ), EPHEDRINE SUL CAP (View Ephedrine Sul Cap Review and Ephedrine Sul Cap Label ), MORPHINE (View Morphine Review and Morphine Label ), NITROUS OXIDE W/ OXYGEN (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), SODIUM CITRATE (View Sodium Citrate Review and Sodium Citrate Label ), SUXAMETHONIUM (SUXAMETHONIUM) (View Suxamethonium (suxamethonium) Review and Suxamethonium (suxamethonium) Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ). Patient was hospitalized.

6568409-8 | Biliary Dilatation, Hypocalcaemia, Hypokalaemia, Intestinal Obstruction, Metabolic Alkalosis
Patient was taking Actiq (View Usage). Patient had the following side effects: biliary dilatation, hypocalcaemia, hypokalaemia, intestinal obstruction, metabolic alkalosis on Jan 18, 2010 from SPAIN Additional patient health information: Female patient , 65 years of age, was diagnosed with complex regional pain syndrome (What is complex regional pain syndrome?) and. Actiq dosage: (900 Mcg), Bu. During the same period patient was treated with MST 100 CONTINUS (MORPHINE SULFATE) ((200 Mg), Oral) (View Mst 100 Continus (morphine Sulfate) Review and Mst 100 Continus (morphine Sulfate) Label ). Patient was hospitalized.

6568374-3 | Dehydration, Frequent Bowel Movements, Loss Of Consciousness, Respiratory Disorder, Vomiting
Adverse event was reported on Jan 19, 2010 by a Female patient taking Actiq (View Usage) (Dosage: 3200 Mcg (800 Mcg,1 In 6 Hr),bu ; 4800 Mcg (1200 Mcg,1 In 6 Hr),bu) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 52 years of age, weighting 145.0 lb, After Actiq was administered, patient had the following side effects: dehydration, frequent bowel movements, loss of consciousness, respiratory disorder, vomiting. During the same period patient was treated with OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), SOMA (View Soma Review and Soma Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

6556784-X | Abdominal Pain Upper, Abnormal Behaviour, Accidental Overdose, Anxiety, Aphthous Stomatitis, Blood Pressure Decreased, Brain Oedema, Bronchopneumonia, Cardiac Disorder
on Mar 20, 2009 Female patient from UNITED STATES , 45 years of age, was diagnosed with migraine (What is migraine?) and was treated with Actiq (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, abnormal behaviour, accidental overdose, anxiety (What is anxiety?), aphthous stomatitis, blood pressure decreased, brain oedema, bronchopneumonia, cardiac disorder. Actiq dosage: See Image. During the same period patient was treated with AVINZA (View Avinza Review and Avinza Label ), VALIUM (View Valium Review and Valium Label ), LIDODERM PATCHES (LIDOCAINE) (View Lidoderm Patches (lidocaine) Review and Lidoderm Patches (lidocaine) Label ). Patient was hospitalized.

6554045-6 | Dependence, No Therapeutic Response
on Jan 10, 2009 Male patient from UNITED STATES , 46 years of age, was treated with Actiq (View Usage). Patient had the following side effects: dependence, no therapeutic response. Actiq dosage: (400 Mcg),bu. During the same period patient was treated with LORTAB (View Lortab Review and Lortab Label ), PERCOCET (View Percocet Review and Percocet Label ), METHADOSE (View Methadose Review and Methadose Label ), SOMA (View Soma Review and Soma Label ), VALIUM (View Valium Review and Valium Label ).

6549834-8 | Acute Myeloid Leukaemia, Malignant Neoplasm Progression
Patient was taking Actiq (View Usage). After Actiq was administered, patient had the following side effects: acute myeloid leukaemia, malignant neoplasm progression on Jan 08, 2010 from FRANCE Additional patient health information: Male patient , 14 years of age, was diagnosed with cancer pain and. Actiq dosage: 400 Mcg (200 Mcg,1 In 1 D),bu. During the same period patient was treated with MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), GRANOCYTE (LENOGRASTIM) (View Granocyte (lenograstim) Review and Granocyte (lenograstim) Label ), ROVALCYTE (VALGANCICLOVIR) (View Rovalcyte (valganciclovir) Review and Rovalcyte (valganciclovir) Label ), WELLVONE (ATOVAQUONE) (View Wellvone (atovaquone) Review and Wellvone (atovaquone) Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ).

6542736-2 | Dental Caries
Adverse event was reported on Jul 27, 2009 by a Female patient taking Actiq (View Usage) (Dosage: 800 Mcg (800 Mcg, 1 In 1 D), Oral) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 40 years of age, weighting 215.0 lb, Patient experienced the following unwanted or unexpected effects: dental caries. During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), CELEBREX (View Celebrex Review and Celebrex Label ), AMBIEN (View Ambien Review and Ambien Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), VALIUM (View Valium Review and Valium Label ), NEURONTIN (View Neurontin Review and Neurontin Label ).

6540460-3 | Malignant Neoplasm Progression
on Jan 06, 2010 Female patient from FRANCE , 71 years of age, was diagnosed with cancer pain and was treated with Actiq (View Usage). Patient had the following side effects: malignant neoplasm progression. Actiq dosage: .

6540407-X | Bedridden, Depression, Device Dislocation, Joint Swelling, Neuropathy Peripheral, Upper Limb Fracture, Walking Aid User
on Jan 04, 2010 Male patient from UNITED STATES , 59 years of age, was diagnosed with pain (What is pain?) and was treated with Actiq (View Usage). After Actiq was administered, patient had the following side effects: bedridden, depression (What is depression?), device dislocation, joint swelling, neuropathy peripheral, upper limb fracture, walking aid user. Actiq dosage: Bu. During the same period patient was treated with FENTANYL PATCH (PARACETAMOL, ORPHENADRINE CITRATE) (TRANSDERMAL PATCH) (View Fentanyl Patch (paracetamol, Orphenadrine Citrate) (transdermal Patch) Review and Fentanyl Patch (paracetamol, Orphenadrine Citrate) (transdermal Patch) Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized and became disabled.

6504240-7 | Anaphylactic Reaction
Patient was taking Actiq (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction on Dec 04, 2009 from UNITED KINGDOM Additional patient health information: Male patient , child 1 years of age, was diagnosed with urethral repair and. Actiq dosage: . During the same period patient was treated with DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), PROPOFOL (View Propofol Review and Propofol Label ). Patient was hospitalized.

6504238-9 | Syncope
Adverse event was reported on Dec 04, 2009 by a Female patient taking Actiq (View Usage) (Dosage: 1800 Mcg (600 Mcg, 3 In 1 D), Bu) . Location: FRANCE , 60 years of age, Patient had the following side effects: syncope. Patient was hospitalized.

6491758-9 | Aphasia, Condition Aggravated, Decreased Appetite, Dehydration, Duodenal Ulcer, Fatigue, Hallucination
on Nov 30, 2009 Female patient from UNITED STATES , 48 years of age, was diagnosed with connective tissue disorder (What is connective tissue disorder?) and was treated with Actiq (View Usage). After Actiq was administered, patient had the following side effects: aphasia (What is aphasia?), condition aggravated, decreased appetite, dehydration, duodenal ulcer, fatigue, hallucination. Actiq dosage: (1600 Mcg, 10-12 Lozenges/day (16000mcg-19200mcg)), Bu. During the same period patient was treated with METHADONE (METHADONE) (View Methadone (methadone) Review and Methadone (methadone) Label ), MORPHINE SULFATE INJ (View Morphine Sulfate Inj Review and Morphine Sulfate Inj Label ), FIORICET (View Fioricet Review and Fioricet Label ), HYDROCORTONE (View Hydrocortone Review and Hydrocortone Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), CYTOTEC (View Cytotec Review and Cytotec Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6480333-8 | Bacterial Infection, Blood Culture Positive, Culture Urine Positive, Haemoglobin Decreased, Incorrect Dose Administered, Loss Of Consciousness, Mental Status Changes, Proteus Infection, Urinary Tract Infection Bacterial
on Nov 23, 2009 Female patient from UNITED STATES , 46 years of age, weighting 176.4 lb, was diagnosed with cancer pain and was treated with Actiq (View Usage). Patient experienced the following unwanted or unexpected effects: bacterial infection (What is bacterial infection?), blood culture positive, culture urine positive, haemoglobin decreased, incorrect dose administered, loss of consciousness, mental status changes, proteus infection, urinary tract infection bacterial. Actiq dosage: Bu. During the same period patient was treated with FENTANYL 100 (Transdermal) (View Fentanyl-100 Review and Fentanyl-100 Label ), METHADONE (METHADONE) (View Methadone (methadone) Review and Methadone (methadone) Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MYLANTA (MAGNESIUM HYDROXIDE, ALUMINIUM HYDROXIDE GEL, DRIED, SIMETICO (View Mylanta (magnesium Hydroxide, Aluminium Hydroxide Gel, Dried, Simetico Review and Mylanta (magnesium Hydroxide, Aluminium Hydroxide Gel, Dried, Simetico Label ), ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6466559-8 | Chest Discomfort, Oesophageal Spasm
Patient was taking Actiq (View Usage). Patient had the following side effects: chest discomfort, oesophageal spasm on Nov 19, 2009 from UNITED STATES Additional patient health information: Female patient , 39 years of age, weighting 154.0 lb, was diagnosed with back pain (What is back pain?), neck pain and. Actiq dosage: 200 Mcg, Tid Up To 600 Mcg, Bu; 3000 Mcg, (600 Mcg, 5 In 1 D), Bu. During the same period patient was treated with LEVOXYL (View Levoxyl Review and Levoxyl Label ), CENESTIN (View Cenestin Review and Cenestin Label ), TOPAMAX (View Topamax Review and Topamax Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ). Patient was hospitalized.

6457813-4 | Blood Pressure Increased, Confusional State, Feeling Cold, Pallor, Respiratory Disorder, Somnolence, Vomiting
Adverse event was reported on Nov 10, 2009 by a Male patient taking Actiq (View Usage) (Dosage: 200 Mcg, Bu) was diagnosed with cerebrovascular accident, pain (What is pain?) and. Location: FRANCE , 74 years of age, After Actiq was administered, patient had the following side effects: blood pressure increased, confusional state, feeling cold, pallor, respiratory disorder, somnolence, vomiting. Patient was hospitalized.

6441807-9 | Aptyalism, Dental Caries, Poor Personal Hygiene, Tooth Loss
on Nov 04, 2009 Male patient from UNITED STATES , 19 years of age, was diagnosed with facial pain and was treated with Actiq (View Usage). Patient experienced the following unwanted or unexpected effects: aptyalism, dental caries, poor personal hygiene, tooth loss. Actiq dosage: (400 Mcg, 6 To 10 Times Per Day), Bu. Patient was hospitalized and became disabled.

6433000-0 | Infusion Site Pain, Neutropenia, Pulmonary Embolism, Pyrexia, Vomiting
on Oct 29, 2009 Female patient from UNITED KINGDOM , 68 years of age, was diagnosed with transitional cell carcinoma and was treated with Actiq (View Usage). Patient had the following side effects: infusion site pain, neutropenia, pulmonary embolism (What is pulmonary embolism?), pyrexia, vomiting. Actiq dosage: Bu. During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), IBUPROFEN TABLETS (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized.

6427878-4 | Coma, Cytolytic Hepatitis, Decubitus Ulcer, Intentional Overdose, Rhabdomyolysis, Suicide Attempt
Patient was taking Actiq (View Usage). After Actiq was administered, patient had the following side effects: coma, cytolytic hepatitis, decubitus ulcer, intentional overdose, rhabdomyolysis, suicide attempt on Oct 26, 2009 from FRANCE Additional patient health information: Male patient , 54 years of age, weighting 189.6 lb, . Actiq dosage: 14400 Mcg (800 Mcg, 18 In 1 Once), Bu. During the same period patient was treated with AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

6425519-3 | Economic Problem, Incorrect Dose Administered, Pain, Paraesthesia, Pruritus, Withdrawal Syndrome
Adverse event was reported on Oct 23, 2009 by a Male patient taking Actiq (View Usage) (Dosage: 1600 Mcg, Bu 200 Mcg, 3-4 Lozenges; Every 3-4 Hours, Bu) . Location: UNITED STATES , 32 years of age, weighting 180.0 lb, Patient experienced the following unwanted or unexpected effects: economic problem, incorrect dose administered, pain (What is pain?), paraesthesia, pruritus, withdrawal syndrome. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), METOPROLOL (METOPROLOL) (View Metoprolol (metoprolol) Review and Metoprolol (metoprolol) Label ), XANAX (METOPROLOL) (View Xanax (metoprolol) Review and Xanax (metoprolol) Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), CELEXA (View Celexa Review and Celexa Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), ZETIA (View Zetia Review and Zetia Label ).

6425517-X | Cartilage Injury, Fall, Intervertebral Disc Protrusion, Joint Sprain, Wrist Fracture
on Apr 05, 2005 Male patient from UNITED STATES , 43 years of age, weighting 260.0 lb, was diagnosed with musculoskeletal pain and was treated with Actiq (View Usage). Patient had the following side effects: cartilage injury, fall (What is fall?), intervertebral disc protrusion, joint sprain, wrist fracture. Actiq dosage: 400 Mcg, Bu 1200 Mcg (1200 Mg, As Needed) Bu 213.3333 Mcg (800 Mcg, 8 In 1 M) Bu. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), DEMEROL (View Demerol Review and Demerol Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), TEMAZEPAM (TEMAZAPAM) (View Temazepam (temazapam) Review and Temazepam (temazapam) Label ). Patient was hospitalized.

6424169-2 | Syncope
on Oct 19, 2009 Female patient from FRANCE , 60 years of age, was treated with Actiq (View Usage). After Actiq was administered, patient had the following side effects: syncope. Actiq dosage: 600 Mcg (200 Mcg, 3 In 1 D), Bu. Patient was hospitalized.

6422990-8 | Bacterial Infection, Blood Culture Positive, Haemoglobin Decreased, Incorrect Dose Administered, Loss Of Consciousness, Mental Status Changes, Proteus Infection, Urinary Tract Infection
Patient was taking Actiq (View Usage). Patient experienced the following unwanted or unexpected effects: bacterial infection (What is bacterial infection?), blood culture positive, haemoglobin decreased, incorrect dose administered, loss of consciousness, mental status changes, proteus infection, urinary tract infection (What is urinary tract infection?) on Oct 16, 2009 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 176.4 lb, was diagnosed with cancer pain and. Actiq dosage: Bu. During the same period patient was treated with FENTANYL (Transdermal) (View Fentanyl Review and Fentanyl Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MYLANTA (MAGNESIUM HYDROXIDE, ALUMINIUM HYDROXIDE GEL, DRIED, SIMETICO (View Mylanta (magnesium Hydroxide, Aluminium Hydroxide Gel, Dried, Simetico Review and Mylanta (magnesium Hydroxide, Aluminium Hydroxide Gel, Dried, Simetico Label ), ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6422989-1 | Fall, Hip Fracture, Product Solubility Abnormal
Adverse event was reported on Feb 14, 2005 by a Male patient taking Actiq (View Usage) (Dosage: 1600 Mcg (800 Mcg, 2 In 1 D),bu; (400 Mcg),bu; (600 Mcg),bu) was diagnosed with neuropathy peripheral and. Location: UNITED STATES , 78 years of age, weighting 159.0 lb, Patient had the following side effects: fall (What is fall?), hip fracture, product solubility abnormal. During the same period patient was treated with DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), LASIX (View Lasix Review and Lasix Label ), COREG (View Coreg Review and Coreg Label ), VASOTEC (View Vasotec Review and Vasotec Label ). Patient was hospitalized.

6422747-8 | Chest Discomfort, Chest Pain
on Oct 20, 2009 Male patient from UNITED STATES , 59 years of age, weighting 130.0 lb, was diagnosed with arthralgia, spinal cord disorder and was treated with Actiq (View Usage). After Actiq was administered, patient had the following side effects: chest discomfort, chest pain (What is chest pain?). Actiq dosage: (1600 Mcg,every 4-6 Hours As Needed),bu. During the same period patient was treated with OXYCODONE (View Oxycodone Review and Oxycodone Label ). Patient was hospitalized.

6420708-6 | Blood Amylase Increased, Lipase Increased, Pancreatitis Acute
on May 10, 2004 Female patient from UNITED STATES , 34 years of age, weighting 165.0 lb, was diagnosed with pain (What is pain?) and was treated with Actiq (View Usage). Patient experienced the following unwanted or unexpected effects: blood amylase increased, lipase increased, pancreatitis acute. Actiq dosage: 3600 Mcg (600 Mcg, 6 In 1 D), Bu; 3600 Mcg (1200 Mcg, 3 In 1 D), Bu. During the same period patient was treated with DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), COUMADIN (View Coumadin Review and Coumadin Label ), EFFEXOR SR (VENLAFAXINE) (View Effexor Sr (venlafaxine) Review and Effexor Sr (venlafaxine) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PROTONIX (PANTROPRAZOLE) (View Protonix (pantroprazole) Review and Protonix (pantroprazole) Label ). Patient was hospitalized.

6420707-4 | Fall, Hip Fracture, Product Quality Issue
Patient was taking Actiq (View Usage). Patient had the following side effects: fall (What is fall?), hip fracture, product quality issue on Feb 14, 2005 from UNITED STATES Additional patient health information: Male patient , 78 years of age, weighting 159.0 lb, was diagnosed with neuropathy peripheral and. Actiq dosage: 1600 Mcg (800 Mcg, 2 In 1 D), Bu. During the same period patient was treated with DURAGESIC (FENTANYL LOZENGE) (View Duragesic (fentanyl Lozenge) Review and Duragesic (fentanyl Lozenge) Label ), LASIX (View Lasix Review and Lasix Label ), COREG (View Coreg Review and Coreg Label ), VASOTEC (ENALAPRIL MELEATE) (View Vasotec (enalapril Meleate) Review and Vasotec (enalapril Meleate) Label ). Patient was hospitalized.